Krilogy Financial’s iShares iBonds Dec 2033 Term Corporate ETF IBDY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$5.39M Buy
207,771
+5,661
+3% +$148K 0.17% 99
2025
Q4
$5.29M Buy
202,110
+1,817
+0.9% +$47.6K 0.18% 91
2025
Q3
$5.21M Buy
200,293
+15,602
+8% +$405K 0.2% 80
2025
Q2
$4.78M Sell
184,691
-9,954
-5% -$252K 0.27% 74
2025
Q1
$4.98M Buy
194,645
+18,077
+10% +$457K 0.32% 62
2024
Q4
$4.43M Buy
176,568
+14,880
+9% +$381K 0.3% 69
2024
Q3
$4.27M Buy
161,688
+9,002
+6% +$233K 0.29% 76
2024
Q2
$3.85M Sell
152,686
-1,252
-0.8% -$31.3K 0.28% 80
2024
Q1
$3.92M Buy
+153,938
New +$3.91M 0.3% 74

Other funds holding IBDY

Krilogy Financial's IBDY Position: Q1 2026 in Review

Krilogy Financial increased its iShares iBonds Dec 2033 Term Corporate ETF (IBDY) stake by 2.8% in Q1 2026, buying an estimated $148K and bringing the position to 207,771 shares worth $5.39M. The position accounts for 0.17% of the portfolio, ranked #99.

Krilogy Financial first reported a position in IBDY in Q1 2024 and has held it in 9 quarters since. 161 funds tracked by Wall St. Rank hold IBDY as of Q1 2026.

  • Krilogy Financial held 207,771 shares of iShares iBonds Dec 2033 Term Corporate ETF worth $5.39M as of Q1 2026.
  • Krilogy Financial bought 5,661 iShares iBonds Dec 2033 Term Corporate ETF shares in Q1 2026, an estimated $148K.
  • iShares iBonds Dec 2033 Term Corporate ETF made up 0.17% of Krilogy Financial's portfolio in Q1 2026, its #99 holding.
  • Krilogy Financial first reported a position in iShares iBonds Dec 2033 Term Corporate ETF in Q1 2024 and has held it in 9 quarters since.
  • 161 funds tracked by Wall St. Rank held iShares iBonds Dec 2033 Term Corporate ETF as of Q1 2026.

Based on Krilogy Financial's 13F filing for Q1 2026, filed 17 Apr 2026.